dA-NHbenzylSCF 3 is a radiosensitizer characterized by its low toxicity to both cancerous and normal cells. However, it significantly enhances the destruction of cancer cells in the presence of ionizing radiation (IR). This compound promotes apoptosis by capturing electrons and inducing DNA double-strand breaks (DSBs). dA-NHbenzylSCF 3 is frequently utilized in research on cancers such as prostate and breast cancer.